2026

1. Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort

   HIV Medicine, Vol. 27, Núm. 1, pp. 58-73

2. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

   Journal of the International AIDS Society, Vol. 29, Núm. 4

3. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

   HIV Medicine, Vol. 27, Núm. 5, pp. 690-709